To facilitate and standardize the in vitro studies on KCs, we investigated the use of HaCaT cells as a suitable model to follow the release of cutaneous inflammatory and repair mediators in response to TNFα or IL-1β, and in relation to different culture conditions and differentiation levels. The gene discussed is IL1B; the disease is dry eye syndrome.